|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14,680.00 JPY | +8.86% |
|
-3.04% | +13.32% |
| 06-05 | Organo Corporation Reports Earnings Results for the Full Year Ended March 31, 2026 | CI |
| 05-13 | Organo Corp - to conduct 5-for-1 stock split for shareholders as of September 30 | RE |
Company Valuation: Organo Corporation
Data adjusted to current consolidation scope
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 116,036 | 165,430 | 353,770 | 292,805 | 625,823 | 675,021 | - | - |
| Change | - | 42.57% | 113.85% | -17.23% | 113.73% | 7.86% | - | - |
| Enterprise Value (EV) 1 | 111,466 | 182,891 | 372,593 | 298,611 | 629,170 | 671,457 | 645,419 | 612,539 |
| Change | - | 64.08% | 103.72% | -19.86% | 110.7% | 6.72% | -3.88% | -5.09% |
| P/E | 12.6x | 14.1x | 20.4x | 12.1x | 22x | 21.6x | 19.6x | 18.5x |
| PBR | 1.53x | 1.92x | 3.47x | 2.42x | 4.38x | 4.1x | 3.65x | 3.21x |
| PEG | - | 0.5x | 0.4x | 0.3x | 1.3x | 2.17x | 1.9x | 3.24x |
| Capitalization / Revenue | 1.04x | 1.25x | 2.35x | 1.79x | 3.52x | 3.32x | 3.08x | 2.95x |
| EV / Revenue | 0.99x | 1.38x | 2.48x | 1.83x | 3.54x | 3.3x | 2.94x | 2.68x |
| EV / EBITDA | - | 10.7x | 15.2x | 9.04x | 15.9x | 15x | 12.8x | 11.6x |
| EV / EBIT | 10.3x | 12x | 16.5x | 9.6x | 16.7x | 16x | 14x | 12.5x |
| EV / FCF | 15.1x | -9.14x | 161x | 16.3x | 65.7x | 24.8x | 22.5x | 19.3x |
| FCF Yield | 6.64% | -10.9% | 0.62% | 6.13% | 1.52% | 4.03% | 4.45% | 5.19% |
| Dividend per Share 2 | 40 | 62 | 102 | 160 | 200 | 226.7 | 246.7 | 260 |
| Rate of return | 1.58% | 1.72% | 1.32% | 2.51% | 1.47% | 1.54% | 1.68% | 1.77% |
| EPS 2 | 200.7 | 255.8 | 376.9 | 525.4 | 617.7 | 679.2 | 748.8 | 791.6 |
| Distribution rate | 19.9% | 24.2% | 27.1% | 30.5% | 32.4% | 33.4% | 32.9% | 32.8% |
| Net sales 1 | 112,069 | 132,426 | 150,356 | 163,269 | 177,654 | 203,433 | 219,267 | 228,967 |
| EBITDA 1 | - | 17,036 | 24,554 | 33,045 | 39,629 | 44,850 | 50,300 | 52,850 |
| EBIT 1 | 10,850 | 15,212 | 22,544 | 31,120 | 37,648 | 41,900 | 46,233 | 48,900 |
| Net income 1 | 9,210 | 11,730 | 17,310 | 24,150 | 28,401 | 31,233 | 34,433 | 36,400 |
| Net Debt 1 | -4,570 | 17,461 | 18,823 | 5,806 | 3,347 | -3,564 | -29,602 | -62,482 |
| Reference price 2 | 2,532.50 | 3,605.00 | 7,700.00 | 6,370.00 | 13,610.00 | 14,680.00 | 14,680.00 | 14,680.00 |
| Nbr of stocks (in thousands) | 45,819 | 45,889 | 45,944 | 45,966 | 45,983 | 45,982 | - | - |
| Announcement Date | 5/12/22 A | 5/12/23 A | 5/13/24 A | 5/13/25 A | 5/13/26 A | - | - | - |
1JPY in Million2JPY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 21.61x | 3.3x | 14.97x | 1.54% | 4.24B | |
| 24.18x | 3.1x | 16.57x | 1.28% | 10.92B | |
| 49.77x | 3.3x | 20.75x | - | 3.85B | |
| 26.71x | - | - | - | 1.24B | |
| 37.42x | 2.59x | 21.94x | 0.42% | 910M | |
| Average | 31.94x | 3.07x | 18.56x | 1.08% | 4.23B | |
| Weighted average by Cap. | 29.04x | 3.16x | 17.28x | 1.3% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 6368 Stock
- Valuation Organo Corporation
Select your edition
All financial news and data tailored to specific country editions
